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Abstract 15 
The lung microbiota is commonly sampled using relatively invasive bronchoscopic procedures. 16 
Exhaled breath condensate (EBC) collection potentially offers a less invasive alternative for lung 17 
microbiota sampling. We compared lung microbiota samples retrieved by protected specimen 18 
brushings (PSB) and exhaled breath condensate collection. We also sought to assess whether 19 
aerosolised antibiotic treatment would influence the lung microbiota and whether EBC was 20 
sensitive enough to detect such changes.  21 
EBC was collected from 6 conscious sheep, and then from the same anaesthetised sheep during 22 
mechanical ventilation. Following the latter EBC collection, PSB samples were collected from 23 
separate sites within each sheep lung. On the subsequent day each sheep was then treated with 24 
nebulised colistimethate sodium. Two days after nebulisation, EBC and PSB samples were again 25 
collected. Bacterial DNA was quantified using 16S rRNA gene qPCR. The V2-V3 region of the 26 
16S rRNA gene was amplified by PCR and sequenced using an Illumina Miseq. Quality control 27 
and operational taxonomic unit (OTU) clustering were performed within mothur. 28 
EBC contained significantly less bacterial DNA than PSB samples. EBC samples from 29 
anaesthetised animals clustered separately by their bacterial community compositions in 30 
comparison to PSB samples and 37 bacterial OTUs were identified which were differentially 31 
abundant between the two sample types. Despite only low concentrations of colistin being 32 
detected in bronchoalveolar lavage fluid, PSB samples were found to differ by their bacterial 33 
compositions pre and post colistimethate sodium treatment. Our findings indicate that microbiota 34 
in EBC samples and PSB samples are not equivalent.  35 
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Importance 36 
Sampling of the lung microbiota usually necessitates performing bronchoscopic procedures 37 
which involve a hospital visit for human participants and the use of trained staff. The 38 
inconvenience and perceived discomfort of participating in this kind of research may deter 39 
healthy volunteers and may not be a safe option for patients with advanced lung disease. This 40 
study set out to evaluate a less invasive method of collecting lung microbiota samples by 41 
comparing samples taken via protected specimen brushings (PSB) to those taken via exhaled 42 
breath condensate (EBC) collection. We found that there was less bacterial DNA in EBC 43 
samples compared to PSB samples and that there were differences between the bacterial 44 
communities in the two sample types. We conclude that while EBC and PSB samples do not 45 
produce equivalent microbiota samples, the study of the EBC microbiota may still be of interest. 46 
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Introduction 47 
The study of the lung microbiota is a relatively new field in comparison to other areas of 48 
microbiota research. Although an increasing number of studies are linking changes in the 49 
composition of the lung bacterial communities to various disease states including allergies, 50 
autoimmune disorders and inflammatory and infectious diseases (1), protocols for studying the 51 
lung microbiota are not standardised, making comparisons between studies difficult.  52 
One issue with studying the lung microbiota is the invasiveness of the sampling techniques; the 53 
most common techniques are bronchoalveolar lavage (BAL) and the collection of protected 54 
specimen brushings (PSB), both of which require the subject to undergo bronchoscopy. The 55 
inconvenience and fear of complications associated with bronchoscopic procedures can lead to 56 
healthy and/or diseased individuals declining to take part in studies (2), leading to a reduction in 57 
the potential pool of volunteers for lung microbiota studies. It is also currently unknown whether 58 
these sampling methods themselves can lead to changes in the lung microbiota.  59 
Exhaled breath condensate (EBC) collection could potentially offer a less invasive method of 60 
taking lung microbiota samples. This method involves condensing exhaled vapour into a liquid 61 
and has previously been used to study exhaled bacteria, viruses and fungi (3-8). However, there 62 
have been no studies using 16S rRNA gene sequencing to compare the bacteria found in EBC 63 
samples to samples taken directly from the lungs. It is, therefore, not known whether it can be 64 
used as a surrogate for more invasive sampling techniques. We sought to assess the feasibility of 65 
using EBC in sheep to study the lung microbiota composition. We have previously used sheep as 66 
a model for studying the lung microbiota (9, 10) due to the anatomical and immunological 67 
similarity of their lungs to those of humans (11-13). In this study we compare EBC samples 68 
 o
n
 April 9, 2017 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
5 
 
collected from conscious sheep and from the same sheep under anaesthesia, to PSB samples 69 
taken from four spatially disparate sites within the lung.  70 
We then extended this to address whether EBC analysis has the capacity to detect changes in 71 
bacterial community compositions by attempting to directly manipulate the lung microbiota with 72 
an inhaled antibiotic (colistimethate sodium (CMS): active against Gram-negative bacteria). 73 
During a previous study we examined the effect of intravenous CMS on the lung microbiota (9). 74 
Whilst we did identify changes in the lung microbiota composition, the longer term systemic 75 
antibiotic treatment used in this study is also likely to have affected the gut microbial 76 
populations. Immunological links between gut and lung immunity, the gut-lung axis, raise the 77 
possibility that such changes may have indirectly influenced the lung microbiota (14). In this 78 
study, we delivered nebulised CMS since this has been shown to lead to lower colistin plasma 79 
concentrations than injected CMS (15), enabling us to discern the direct effect of antibiotic 80 
treatment on respiratory bacterial communities. 81 
A far greater quantity of bacterial DNA was isolated from PSB samples relative to EBC samples. 82 
We found that whilst there was some overlap between the types of bacteria found in these 83 
samples, EBC samples did cluster separately from PSB samples by their bacterial community 84 
compositions. Lastly, despite our antibiotic treatment regime only producing low concentrations 85 
of colistin in the lung epithelial lining fluids (the prodrug CMS is hydrolysed in vivo to the active 86 
form of the drug, colistin), significant differences in community composition were found 87 
between PSB samples derived pre- and post-treatment.   88 
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Methods and materials 89 
Animals 90 
Six commercially sourced, castrated, male Suffolk-cross sheep aged 14 months were used in this 91 
study. All animal experiments were approved by the Roslin Institute Animal Welfare and Ethics 92 
Committee and were subject to the Animals (Scientific Procedures) Act of 1986. Sheep had 93 
previously been housed outdoors as part of a large flock but were moved indoors before the 94 
study and remained indoors until the study end. Sheep were separated into two pens sharing the 95 
same airspace. One pen contained sheep ED951, ED952 and ED953 while the other contained 96 
sheep ED954, ED955 and ED956. The rectal temperatures and weights of all animals were taken 97 
prior to initial respiratory tract sampling. The animals weighed on average 49.2 ± 3.4 kg (mean ± 98 
standard deviation (SD)) and rectal temperatures were measured as 38.9 ± 0.89°C. 99 
 100 
Experimental design 101 
Conscious animals were confined in a yoke head restraint holding crate and EBC was collected 102 
for 10 mins using an RTubeVENT with cooling sleeve (Respiratory Research, Charlottesville, 103 
VA, USA) attached to a face mask. The sheep inhaled through a one-way inspiratory valve and 104 
expired through the RTubeVENT (Figure 1). The exhaled breath condensate samples from 105 
conscious sheep (EBC (cons)) were transferred from the RTubeVENT into Eppendorf tubes 106 
following the manufacturer’s instructions and were frozen on dry ice within an hour of 107 
collection.  108 
The sheep were then anaesthetised (3-5 hours later) following a procedure that has previously 109 
been described (16). Bronchoscopy was performed by use of an endotracheal tube. During 110 
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anaesthesia, EBC samples were collected for 10 mins by incorporating an RTubeVENT within 111 
the expiratory limb of the anaesthetic circuit (Figure 1). The condensate was again transferred 112 
into Eppendorf tubes. The exhaled breath condensate samples from the anaesthetised sheep (EBC 113 
(anaes)) were frozen on dry ice within an hour of collection. PSB samples (Disposable 114 
Microbiology Brush: ConMed, Utica, NY, USA) were taken from the left ventral diaphragmatic 115 
1 (LVD1), right ventral diaphragmatic 1 (RVD1), right caudal diaphragmatic (RCD) and left 116 
caudal diaphragmatic (LCD) lung segments (Figure 2). Brushes were cut into phosphate 117 
buffered saline (PBS: D8537, Sigma-Aldrich, Irvine, UK) for storage. For each sampling day, an 118 
unused protected specimen brush was cut into PBS to act as a control.  119 
Eighteen hours after recovery from anaesthesia, sheep were administered 2,000,000 IU of CMS 120 
in 4 ml distilled water by inhalation (Colomycin for Injection: Forest Laboratories UK ltd., 121 
Dartford, UK). Restraint of the conscious sheep was as described above and the CMS was 122 
delivered using a face mask connected via the inspiratory limb to an eflow rapid nebuliser (PARI 123 
Respiratory Equipment Inc., Midlothian, VA, USA). This treatment was repeated 6 hours later. 124 
Two days after the first CMS dose was administered, EBC (cons), EBC (anaes) and PSB samples 125 
were again collected as described above. Sheep were killed by barbiturate overdose and 126 
exsanguination and blood samples were collected. Blood was centrifuged at 2500g for 5 mins 127 
and the serum was removed and frozen on dry ice. Immediately post-mortem, 20 ml aliquots of 128 
PBS were used to collect BAL fluid. The urea concentration in plasma and BAL fluid was used 129 
to calculate the dilution factor of lung epithelial lining fluid in BAL fluid (17). 130 
 131 
Quantitation of colistin in BAL fluid of sheep 132 
 o
n
 April 9, 2017 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
8 
 
BAL fluid was centrifuged at 1400g for 5 mins to remove cells prior to colistin quantification. 133 
Quantitation of colistin in ovine BAL fluid essentially follows the method previously published 134 
by Marchand et al. (18). Briefly, colistin sulfate (Item no. 17584 (mixture of A and B isoforms): 135 
Cayman Chemicals, Ann Arbor, Ml, USA) was dissolved in H2O to 1 mg/ml and a series of 7 136 
calibrant solutions were created by diluting the stock solution into blank BAL fluid to cover the 137 
range from 100 to 0.07 µg/ml. Polymyxin B (Sigma-Aldrich, Irvine, UK) was used as an internal 138 
standard and was dissolved in water to 300 µg/ml. 2 µl of internal standard was added to 200 µl 139 
of each of the calibrant solutions and to 200 µl of each of the test samples. 800 µl of H2O & 140 
0.1% (v/v) formic acid was added to each of the samples/calibrants and each was partially 141 
purified by binding to a DSC-18 SPE cartridge (Sigma-Aldrich, Irvine, UK), eluting with 400 µl 142 
MeOH & 0.1% (v/v) formic acid. The eluted fractions were dried under vacuum and 143 
reconstituted in 50 µl of H2O & 0.1% (v/v) formic acid for subsequent analysis. 144 
All calibrants and samples were centrifuged at 13000g for 5 mins to pellet any precipitate and 145 
then were analysed by online LC-MS/MS in duplicate. 5 µl aliquots were injected onto an Ace 146 
Ultracore 2.5 SuperC18 HPLC column (75 x 2.1 mm) pre-equilibrated at 98% (v/v) buffer A, 147 
where HPLC buffer A was H2O with 0.1% (v/v) formic acid and 0.01% (v/v) trifluoroacetic acid, 148 
whilst HPLC buffer B was acetonitrile with 0.1% (v/v) formic acid and 0.01% (v/v) 149 
trifluoroacetic acid. The HPLC separation was developed by the following steps: from 2% buffer 150 
B on 0 mins to 18% buffer B on 1 min; 22% buffer B on 3.5 mins; 100% buffer B on 4 mins; 151 
100% buffer B on 5 mins and returning to 2% buffer B on 6 mins for 5 mins to re-equilibrate. 152 
The flow rate was 200 µl/min and the eluent was passed directly to the electrospray source of an 153 
Amazon ETD ion trap mass spectrometer (Bruker, Billerica, MA, USA) operated in positive ion 154 
mode. The mass spectrometer was operated under multiple reaction monitoring conditions, using 155 
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parent ions of 578.3, 585.3 and 602.3 (representing the double charged ion of colistin B, A and 156 
polymyxin B respectively), fragmentation amplitudes of 0.8 and cut offs of 140 in each case. 157 
Calibration curves and colistin concentrations were calculated by Bruker’s proprietary software 158 
QuantAnalysis, using the following reporter ions: colistin A 526.3, 535.3, 567.3, 576.3; colistin 159 
B 519.3, 528.3, 560.800, 569.3; Polymyxin B 543.300, 552.300, 584.300, 593.3. 160 
 161 
DNA extraction 162 
DNA extraction was carried out as described previously (10) using the MO BIO PowerSoil DNA 163 
Isolation Kit (MO BIO Laboratories inc., Carlsbad, CA, USA). All DNA extractions were 164 
carried out using the same lot of extraction kit, as the contamination present in different lots of 165 
the same make of kit have been shown not to be consistent (19). Samples were randomly 166 
assigned to one of four DNA extraction batches and for each of these batches an extraction kit 167 
reagent only control was produced (sample groupings can be found in Dataset S1).  168 
 169 
16S rRNA gene amplification and sequencing 170 
The V2-V3 variable regions of the 16S gene were amplified as described previously (10). A 171 
nested PCR protocol was used in order to decrease the potential bias introduced by the use of 172 
barcoded primers by only including primers with Illumina adaptor sequences and barcodes in the 173 
second PCR round (20). The first round used the V1-V4 primers 28F (‘5-174 
GAGTTTGATCNTGGCTCAG-3’) and 805R (‘5-GACTACCAGGGTATCTAATC-3’) and the 175 
second round used the V2-V3 primers 104F (‘5-GGCGVACGGGTGAGTAA-3’) and 519R (‘5-176 
GTNTTACNGCGGCKGCTG-3’) with Illumina adaptor sequences and barcodes (Dataset S1). 177 
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The PCR conditions for the first round were 94°C for 2 min followed by 20 cycles of 94°C for 1 178 
min, 55°C for 45 s and 72°C for 1.5 min followed by 72°C for 20 min. The conditions for the 179 
second round were 98°C for 30 s followed by 20 cycles of 98°C for 10 s, 67°C for 30 s and 72°C 180 
for 10 s followed by 72°C for 2 min  Q5 High-Fidelity 2X Master Mix (New England BioLabs., 181 
Ipswich, MA, USA) was used for all reactions. After each PCR round, amplicons were purified 182 
using the AMPure XP PCR purification system (Beckman Coulter, Brea, CA, USA). The Human 183 
Microbiome Project Mock Community HM-783D (obtained through BEI Resources, NIAID, 184 
NIH) also underwent PCR alongside samples and controls. The Qubit dsDNA HS Assay Kit 185 
(Thermo Fisher Scientific, Hemel Hempstead, UK) was used to calculate the quantity of DNA in 186 
each sample then samples were pooled into a sequencing library. Sequencing was performed on 187 
an Illumina Miseq (Illumina, San Diego, CA, USA) producing 250bp paired-end reads.  188 
 189 
Bioinformatic and statistical analysis  190 
Primers were removed with cutadapt (21) and sequences with greater than one base error per 10 191 
bases were discarded. Quality control, taxonomic assignment and OTU clustering were 192 
performed in mothur (22) as described previously (10). The data was subsampled to the 193 
minimum number of sequence reads found in one of our samples (11675). Except where stated, 194 
the following analyses were all performed within mothur. 195 
 Good’s coverage values were calculated to estimate sample coverage (23). Distance matrices 196 
were constructed using Yue Clayton theta values (24) and analysis of molecular variance 197 
(AMOVA) was used to compare groups of samples by their bacterial composition (25). 198 
Homogeneity of molecular variance (HOMOVA) was used to compare groups by their variation 199 
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(26). Principle coordinate analysis (PCOA) graphs were constructed to visualise sample 200 
clustering. The mothur command corr.axes was used to correlate bacterial OTUs to the axes of 201 
the PCOA graphs using the Spearman's rank correlation coefficient (r). The Bonferroni 202 
correction was used to correct for multiple statistical tests. The Inverse Simpson’s index was 203 
employed to measure microbial diversity and the Chao 1 index was employed to measure 204 
richness. Metastats was used to identify OTUs which were significantly different between groups 205 
(27) except where more than two groups were compared in which case indicator analysis was 206 
used (28).  207 
To compare groups statistically where data was non-parametric, the Mann-Whitney U test was 208 
used if the groups were independent and the Wilcoxon Signed Rank test was used where samples 209 
were related (performed in SPSS Statistics 21, IBM Analytics). Boxplots for qPCR data were 210 
constructed in SPSS. Heatmaps were constructed in R (Version 3.2.2, R Foundation for 211 
Statistical Computing (https://www.R-project.org)) using the packages gplots (29), heatplus (30), 212 
RColorBrewer (31) and Vegan (32). 213 
 214 
qPCR 215 
Quantification of the V3 region of the 16S rRNA gene was carried out using a previously 216 
described method (10). A standard curve was generated using DNA extracted from Pseudomonas 217 
aeruginosa strain PA0579 using 9 serial dilutions ranging from 14.2 ng/µl to 1.42 x 10-7 ng/µl 218 
(Quantified by the Qubit dsDNA HS Assay). The 0.142 ng/µl dilution served as a positive 219 
control for all qPCR reactions. The average CT value of no template controls was 28.7.  220 
 o
n
 April 9, 2017 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
12 
 
qPCR was performed using 1 µl of extracted DNA solution, the primers UniF340 (‘5-221 
ACTCCTACGGGAGGCAGCAGT-3’) and UniR514 (‘5-ATTACCGCGGCTGCTGGC-3’) at a 222 
final concentration of 0.4 µM and the LightCycler 480 SYBR green I master mix (Roche 223 
Applied Science, Mannheim, Germany). The qPCR run consisted of a preincubation step (50°C 224 
for 2 min then 95°C for 10 s), an amplification step (45 cycles of 95°C for 30 s, then 63°C for 30 225 
s) and a melting cycle.  226 
 227 
Data availability 228 
Sequencing reads can be accessed at Bioproject accession number PRJNA337937. 229 
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Results 230 
Analysis of sequence quality and controls 231 
DNA was extracted from respiratory samples and controls and the V2-V3 variable regions of the 232 
16S rRNA gene were amplified by PCR, then sequenced. After forming contigs from forward 233 
and reverse reads, various quality controls steps were undertaken which reduced the total 234 
sequence numbers by 25.8%. The lowest Good’s coverage estimate value amongst the samples 235 
was 0.996 indicating that at least 99.6% of the bacteria in this sample were identified. The 236 
sequence error rate was 0.18% and the average number of reads per sample was 39195 ± 11535 237 
(mean ± SD). In total 867 OTUs were identified.  238 
The Human Microbiome Project Mock Community HM-783D, containing the 16S rRNA genes 239 
of 20 bacterial species in staggered quantities and fixed ratios (1,000 to 1,000,000 copies per 240 
organism per µl), was processed alongside samples. Some biases were identified (Dataset S2). 241 
Three species were incorrectly identified to species level (Acinetobacter baumannii misidentified 242 
as Acinetobacter rhizosphaerae, Clostridium beijerinckii misidentified as Clostridium butyricum 243 
and Neisseria meningitides misidentified as Neisseria cinerea). Two of the bacterial species 244 
which were present in low numbers in the original community were not identified at any 245 
taxonomic level: Actinomyces odontolyticus and Bacteroides vulgatus. Their absence is likely 246 
due to the fact that they were in low abundance rather than the inability of our protocol to 247 
amplify and identify them, as they have previously been identified using the same protocol on a 248 
non-staggered version of the same mock community (10). We were also previously able to 249 
identify Enterococcus faecalis to genus level whereas in this study it could not be identified 250 
except potentially as OTU 10: Bacilli (class). This discrepancy, combined with the fact that 251 
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E.faecalis is in low abundance in the staggered mock community leads us to believe that this 252 
identification is incorrect. 253 
As lung bacteria are in low abundance, lung samples are at particular risk from contamination by 254 
bacterial DNA originating from DNA extraction kit reagents. Therefore, as well as mock 255 
community controls, DNA extraction kit reagent controls were produced. DNA was extracted 256 
from samples in four batches and a reagent control was included with every batch. The bacterial 257 
OTUs identified in extraction kit controls did not occur consistently in samples from the same 258 
batch (Figure 3). Samples did cluster by DNA extraction batch (AMOVA: P<0.001) and 30 259 
OTUs were found to be indicative of specific batches (Dataset S3). However, when these OTUs 260 
were removed from the dataset, samples still clustered by extraction batch (AMOVA: P=0.014), 261 
indicating that clustering was not entirely due to the presence of these OTUs. It is possible that 262 
some of these OTUs may be found naturally within the sheep respiratory system (eg. 263 
Micrococcus luteus – common coloniser of the human upper respiratory tract). We therefore 264 
decided not to remove these OTUs from our dataset. Since samples were randomly assigned to 265 
extraction batches, clustering by batch would be unlikely to lead to false positive statistical tests. 266 
However, there is the possibility that the presence of contaminating organisms may increase 267 
heterogeneity and thereby also increase stochastic noise.  268 
In controls the most abundant OTUs on average were: PSB controls (Corynebacterium: 14.4%, 269 
Enterobacteriaceae: 10.9%, Intrasporangiaceae: 3.6%) and DNA extraction kit reagent controls 270 
(Burkholderia: 14.0%, Neisseriaceae: 10.5%, Aggregatibacter: 7.7%). The most abundant OTUs 271 
(on average) in the different sample types were: PSB samples (Staphylococcus equorum: 10.7%, 272 
Mannheimia: 6.5%, Staphylococcus sciuri: 5.6%), EBC (cons) (Staphylococcus equorum: 5.5%, 273 
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Neisseriaceae: 4.7%, Paracoccus: 4.3%) and EBC (anaes) (Staphylococcus equorum: 5.1%, 274 
Staphylococcus epidermidis: 3.7%, Peptostreptococcus anaerobius: 3.2%).  275 
 276 
PSB samples contain more bacterial DNA than EBC samples 277 
The V3 region of the 16S rRNA gene was quantified in our samples using qPCR. On average, 278 
PSB samples contained 1.53 x 10-5 ± 2.96 x 10-5 ng/µl (mean ± SD) bacterial DNA (34200 ± 279 
66100 16S copy numbers/µl) while EBC samples from conscious and anaesthetised sheep 280 
contained 4.28 x 10-7 ± 5.34 x 10-7 ng/µl (955 ± 1190 16S copy numbers/µl) and 2.38 x 10-7 ± 281 
7.12 x 10-8 ng/µl (531 ± 159 16S copy numbers/µl) respectively (Figure 4). DNA extraction kit 282 
reagent only controls contained 1.82 x 10-7 ± 2.21 x 10-8 ng/µl (406 ± 49 16S copy numbers/µl) 283 
while PSB controls and qPCR water controls contained 1.84 x 10-7 ± 1.05 x 10-8 ng/µl (411 ± 23 284 
16S copy numbers/µl) and 1.98 x 10-7 ± 2.06 x 10-8 ng/µl (442 ± 46 16S copy numbers/µl) 285 
respectively. 286 
All respiratory samples contained significantly more DNA than controls (Mann-Whitney: 287 
P<0.005 for all sample types). EBC samples from conscious and anaesthetised animals did not 288 
contain significantly different quantities of DNA (Wilcoxon signed-rank: P=0.182); however, 289 
PSB samples contained significantly more DNA when compared to both EBC (cons) (Wilcoxon 290 
signed-rank: P=0.002) and EBC (anaes) (Wilcoxon signed-rank: P=0.002) samples. 291 
 292 
No significant clustering of EBC by sampling method 293 
Since EBC samples from conscious sheep would be expected to include more bacteria from the 294 
upper respiratory tract than EBC samples from anaesthetised sheep, it was expected that these 295 
 o
n
 April 9, 2017 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
16 
 
two groups of samples would cluster separately from one another. However, no significantly 296 
separate clustering was observed (AMOVA: P=0.994). Despite this lack of separate clustering, 297 
EBC samples taken from the same sheep while it was conscious or anaesthetised did not contain 298 
the same bacterial communities, as can be observed in Figure 5.   299 
The richness and diversity of bacterial communities were not significantly different between the 300 
two groups (Wilcoxon signed rank: P=0.583, P=0.595 respectively). When examined using 301 
metastats, there were significant differences in the quantities of several OTUs between these 302 
groups but all of these OTUs were present at low abundance (<1% abundant on average in each 303 
group).  304 
 305 
PSB samples and EBC (anaes) samples cluster separately by their bacterial communities 306 
We next investigated whether PSB and EBC samples contained equivalent bacterial 307 
communities. We compared PSB samples to EBC (anaes) samples as we hypothesised that these 308 
would be less likely to be contaminated by upper respiratory tract microbes than EBC (cons) 309 
samples. As well as containing a larger quantity of bacterial DNA, PSB samples also contained 310 
significantly different bacterial communities from EBC (anaes) samples (AMOVA: P=0.011, 311 
Figure 6). This may be explained by the difference in variation between the two groups 312 
(HOMOVA: P=0.026). Bacterial communities from PSB samples were also found to be 313 
significantly richer (Wilcoxon Signed Rank: P=0.006) but there was no significant difference in 314 
diversity (Wilcoxon Signed Rank: P=0.48). One OTU designated Pseudomonas veronii, which 315 
was the 4th most abundant OTU in PSB samples, was found to be significantly more abundant in 316 
PSB samples (Metastats q-value=0.046, PSB samples (mean ± SD): 3.9% ± 1.3%, EBC: only 317 
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one sequence read found in one sample). The P.veronii OTU was not found in any of the PSB 318 
controls, indicating that it is likely that its presence is not due to contamination. This indicates 319 
that the EBC samples do not simply contain a subset of the most abundant OTUs from PSB 320 
samples. An additional 36 low abundance OTUs (<1% abundant on average in either group) 321 
were found to be significantly different between the two groups by Metastats.  322 
We considered that, since EBC (anaes) samples contained far less bacterial DNA than PSB 323 
samples, they may have been more affected by contamination and this may be why these sample 324 
types cluster separately. However, the five most abundant OTUs found in DNA extraction kit 325 
reagent controls (Burkholderia, Neisseriaceae, Aggregatibacter, Pseudomonadaceae and 326 
Methylobacterium) were not found to be significantly differently represented between PSB 327 
samples and EBC (anaes) samples (Metastats q-value=1). It therefore seems unlikely that the 328 
separate clustering of these groups is due merely to the increased effect of contamination on EBC 329 
(anaes) samples. 330 
 331 
Changes in the bacterial communities found in respiratory samples pre and post CMS 332 
treatment 333 
For both EBC (cons) and EBC (anaes) samples, pre and post treatment samples did not differ 334 
significantly by bacterial community structure (AMOVA: P=0.449, P=0.094 respectively). 335 
However, the bacterial communities found in PSB samples were found to be significantly 336 
different pre and post treatment (AMOVA: P=0.014, Figure 7). This significantly separate 337 
clustering was not merely due to differences in variation between the two groups (HOMOVA: 338 
P=0.87).  The OTU P.veronii was increased in post treatment samples (Metastats q-value: 339 
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P=0.043, Pre-treatment (mean ± SD): 0.74% ± 0.39%, Post-treatment: 7.1% ± 2.4%) and a 340 
further 97 low abundance (<0.1%) OTUs were found to significantly differentiate pre and post 341 
treatment samples.  342 
Using the Wilcoxon signed rank test, it was found that the concentrations of DNA in respiratory 343 
samples pre and post CMS treatment did not differ significantly: PSB samples (P=0.689), EBC 344 
(cons) (P=0.345) and EBC (anaes) samples (P=0.248). The concentrations of colistin A 345 
identified in sheep lungs are shown in Table 1.   346 
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Discussion 347 
In this study we sought to identify whether invasive lung microbiota sampling techniques could 348 
be replaced by a less invasive method. We compared the quantity of bacterial DNA and the 349 
bacterial communities from samples taken by PSB and EBC collection in six sheep at two 350 
sampling points. EBC was collected from both conscious and anaesthetised animals. During 351 
mechanical ventilation the animals were intubated, meaning that the exhaled breath collected was 352 
derived only from the lower respiratory tract; by comparing these samples to those taken from 353 
conscious animals it should be possible to analyse the extent of contamination by bacteria from 354 
the upper respiratory tract on EBC (cons) samples. We found that EBC samples contained 355 
significantly less bacterial DNA than PSB samples and that PSB samples clustered separately by 356 
the composition of their bacterial communities to EBC (anaes) samples. EBC (anaes) and EBC 357 
(cons) samples did not cluster separately from one another. 358 
Studies examining the utility of EBC for identifying lung colonising microorganisms have shown 359 
variable results. A study comparing EBC and sputum samples from asthma patients showed a 360 
100% overlap in the culturable fungi identified between the two sample types (5) and a study 361 
examining the bacterial pathogens cultured from BAL and EBC samples in patients with 362 
ventilator associated pneumonia showed high concordance between the two sampling methods 363 
(33). In comparison, when PCR assays for ten common respiratory pathogens were performed on 364 
EBC and sputum samples from chronic obstructive pulmonary disease patients the results were 365 
found not to correlate well (34). EBC collection has also previously been found to be inefficient 366 
at detecting Mycobacterium tuberculosis (35), influenza viruses (36) and the common cystic 367 
fibrosis pathogens Pseudomonas aeruginosa and Burkholderia cepacia (37). 368 
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Some concerns have been raised about the use of EBC in respiratory research since the epithelial 369 
lining fluid contained in these samples is often variable and is very highly diluted with water 370 
vapour (38). This dilution could explain the far lower concentrations of bacterial DNA we 371 
identified in EBC samples in comparison to PSB samples. It is also likely that PSBs would be 372 
more efficient at sampling biofilms adhered to the lung mucosa which could explain some of the 373 
differences observed between the two sample types. The difference between the bacterial 374 
communities found in PSB samples and EBC may also be partially explained by how EBC is 375 
formed. The exact origin of EBC is still under debate but it has been suggested that differences 376 
observed between BAL and EBC samples could be explained by the fact that they sample 377 
different compartments of the lung (39). Whilst it might be assumed that EBC would be derived 378 
from both the central and peripheral airway compartments, which would perhaps explain the 379 
differences between these samples and PSB samples, Bondesson et al. conclude that the majority 380 
of EBC is in fact derived from the central airways (40). Without a better understanding of how 381 
EBC is formed and what influences its composition, we are unable to account for the differences 382 
we observed between the two sampling types. 383 
Despite the fact that the concentrations of colistin found in the lungs were quite low after 384 
nebulised CMS treatment, a significant difference was observed in the bacterial communities 385 
from PSB samples pre and post treatment. In a previous study we found that the relative 386 
proportion of Gram negative bacteria in the lung microbiota was reduced post injected CMS 387 
treatment (excluding Pseudomonadales) (9). However, members of the Pseudomonadales 388 
generally increased in relative abundance or remained stable after treatment. It is therefore 389 
interesting to note that whilst in this study we did not find a significant reduction in the 390 
abundance of Gram negative bacteria in PSB samples (data not shown), an OTU belonging to the 391 
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Pseudomonadales (P.veronii) was significantly increased in these samples post CMS treatment. 392 
It is possible that even at low concentrations the colistin may have had some effect on the lung 393 
bacteria or that the sampling strategy may itself in some way lead to changes in the lung 394 
microbiota, but at the moment this is purely speculative. All samples were randomised prior to 395 
DNA extraction and PCR amplification therefore observed differences were not due to samples 396 
from one time-point being processed separately from those from the other time-point. 397 
In conclusion, the differences we observe between PSB samples and EBC samples lead us to not 398 
recommend using EBC collection as a replacement for more invasive lung sampling techniques. 399 
However, the EBC microbiota may still be an interesting avenue of study despite the fact that the 400 
small quantities of bacterial DNA in these samples does leave them more vulnerable to 401 
contamination and any future studies would have to be designed with this in mind.  402 
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Figure Legends 531 
Figure 1: A) EBC was collected from conscious animals while they were restrained in a yoke 532 
head restraint holding crate. A face mask was attached and sheep inhaled through a short tube 533 
with an inlet valve and exhaled through an RTubeVENT. B) EBC was collected from 534 
anaesthetised, mechanically ventilated animals by placing the RTubeVENT in-line with the 535 
expiratory limb of the ventilator, near to the sheep’s head. 536 
Figure 2: Diagram of the sheep lung. PSB samples were taken pre and post colistimethate 537 
sodium treatment from the RVD1 (right ventral diaphragmatic 1), LVD1 (left ventral 538 
diaphragmatic 1), RCD (right caudal diaphragmatic) and LCD (left caudal diaphragmatic) lung 539 
segments. Figure adapted with permission from previous work (16). 540 
Figure 3: Heatmap showing samples grouped by batch, based upon the time DNA was extracted 541 
from the samples. Bacterial OTUs were included where they had an abundance of ≥5% in at least 542 
one sample. OTUs which were ≥5% abundant in a DNA extraction kit reagent control are 543 
indicated by colour (batch 1 = green, batch 2 = pink, batch 3 = blue and batch 4 = yellow). DNA 544 
extraction kit reagent controls are labelled as Extraction Kit Batch n. EBC samples from 545 
conscious and from anaesthetised sheep are labelled EBC (cons) and EBC (anaes) respectively. 546 
OTUs which were >5% abundant in an extraction kit control do not consistently appear in all 547 
samples in the same batch.  548 
Figure 4: Boxplot showing the log 16S rRNA gene concentrations found in sheep respiratory 549 
samples (EBC samples from conscious and anaesthetised animals and PSB samples) and controls 550 
(protected specimen brushes, DNA extraction kit reagents and qPCR reagents). Outliers were 551 
defined by SPSS as either ‘out’ values (circles) or ‘extreme’ values (stars). PSB samples 552 
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contained significantly more bacterial DNA (P<0.005) than any other respiratory sample type or 553 
control.  554 
Figure 5: Heatmap showing EBC samples grouped by sheep and time-point. DNA extraction kit 555 
reagent controls are labelled as Extraction Kit Batch n. EBC samples from conscious and from 556 
anaesthetised sheep are labelled EBC (cons) and EBC (anaes) respectively. Bacterial OTUs were 557 
included where they had an abundance of ≥5% in at least one sample. As can be observed, EBC 558 
samples taken from the same sheep when it was conscious and when it was anaesthetised did not 559 
necessarily contain the same bacterial OTUs.  560 
Figure 6: PCOA graph showing the significantly separate clustering of EBC (anaes) and PSB 561 
samples from sheep (AMOVA: P=0.011), which may be due to the difference in variation 562 
between the two sample types (HOMOVA: P=0.026). The OTUs which most contributed to 563 
samples moving in a positive or negative direction along either axis and which had p-values of 564 
<0.00058 (defined by the Bonferroni correction as 0.5 divided by the total number of OTUs), 565 
according to the corr.axes command within mothur, are listed. As this graph is only 566 
representative of 20.3% of the total variability present between samples, caution should be taken 567 
when interpreting how clustered sample groups appear. 568 
Figure 7: PCOA graph showing the significantly separate clustering of PSB samples from sheep 569 
pre and post CMS treatment (AMOVA: P=0.014). The OTUs which most contributed to samples 570 
moving in a positive or negative direction along either axis and which had p-values of <0.00058 571 
(defined by the Bonferroni correction as 0.5 divided by the total number of OTUs), according to 572 
the corr.axes command within mothur, are listed. As this graph is only representative of 24% of 573 
the total variability present between samples, caution should be taken when interpreting how 574 
clustered sample groups appear.  575 
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Tables 576 
Table 1: Colistin A concentrations in sheep epithelial lining fluid  577 
Sheep Colistin A* concentration 
(Mean ± SD) 
Dilution of epithelial 
lining fluid in BAL 
Colistin A concentration 
corrected for dilution (Mean) 
ED951 0.346 ± 0.056 ng/µl 5.45 1.89 ng/µl 
ED952 0.320 ± 0.034 ng/µl 4.18 1.34 ng/µl 
ED953 0.290 ± 0.061 ng/µl 6.45 1.87 ng/µl 
ED954 1.549 ± 0.251 ng/µl 15.75 24.40 ng/µl 
ED955 0.625 ± 0.159 ng/µl 11.43 7.15 ng/µl 
ED956 0.222 ± 0.017 ng/µl 29.5 6.56 ng/µl 
*colistin B values were too low to be calculated accurately   578 
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